PDL BioPharma, Inc. PDLI

Other  —  Other
Market cap
—
P/E
0.0×

An Income Statement, also known as a Profit and Loss Statement, summarizes a company's revenues, expenses, and profits over a specific period. It highlights how revenue is transformed into net income, showcasing operational efficiency. Key components include total revenue, cost of goods sold (COGS), gross profit, operating expenses, and net profit. Businesses use the Income Statement to assess financial performance, make strategic decisions, and ensure profitability. Investors and stakeholders analyze it to gauge the company’s financial health and future growth potential.

Older periods Sep '19 Dec '19 Mar '20 Jun '20
Revenue

+8 more TTM periods

103.44 54.76 54.06 51.81
Gross Profit
68.23 1.14 1.38 1.42
Operating Income
25.47 (99.81) (123.47) (127.98)
EBT
(7.24) (73.74) (110.68) (114.09)
Income after Tax
(18.15) (70.69) (94.01) (98.92)
Net Income Common
0.76 (70.41) (108.81) (154.37)
Gross Margin
65.96% 2.08% 2.55% 2.74%
EBIT Margin
24.62% (182.29%) (228.41%) (247.02%)
Net Profit Margin
0.73% (128.59%) (201.30%) (297.95%)
Free Cash Flow Margin
63.63% 128.36% (85.48%) (13.21%)
EBITDA
43.10 (82.40) (107.97) (114.58)
EBIT
25.47 (99.81) (123.47) (127.98)

Show all line items

In millions of $ except per-share values · columns are period end dates